NUCB1 and neoplasm: The percentages of SHON-Cyto−/Nuc−, SHON-Cyto−/Nuc+ and SHON-Cyto+/Nuc+ tumours were 25% (328/1,299), 8% (106/1,299) and 8% (99/1,299), respectively.